|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.75 USD | 0.00% |
|
-6.25% | +36.36% |
| Apr. 19 | Nuo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 19 | Exor-backed NUO invests in Italian teenage clothing chain Subdued | RE |
Nuo Therapeutics, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 0.608525 million compared to USD 0.11225 million a year ago. Net loss was USD 3.17 million compared to USD 3.17 million a year ago.
Basic loss per share from continuing operations was USD 0.08 compared to USD 0.08 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +36.36% | 33.18M | |
| +9.42% | 114B | |
| +11.84% | 104B | |
| -14.15% | 22.41B | |
| -1.05% | 22.28B | |
| -5.29% | 19.07B | |
| -38.29% | 18B | |
| -4.16% | 17.89B | |
| +7.99% | 14.28B | |
| +36.24% | 12.55B |
NUO THERAPEUTICS, INC. 